Deoxyadenosine
Especificaciones
958-09-8Número CAS
213-488-7Número CE
(2R,3S,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-olNombre IUPAC
C10H13N5O3Fórmula química
251.24 g/molPeso molecular
2'-deoxyadenosine; deoxyadenosine; 958-09-8; 2-Deoxyadenosine; Desoxyadenosine; Adenyldeoxyriboside; Adenine deoxyribose; ADENOSINE, 2'-DEOXY-; (2R,3S,5R)-5-(6-Aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; CHEBI:17256; Adenine deoxy nucleoside; P582C98ULC; DTXSID10883624; (2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 9H-Purin-6-amine, 9-(2-deoxy-beta-D-ribofuranosyl)-; 9-(2-Deoxy-beta-D-erythro-pentofuranosyl)adenine; 9H-Purin-6-amine, 9-(2-deoxy-beta-D-erythro-pentofuranosyl)-; beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1,2-dideoxy-; 9-(2-deoxy-beta-D-ribofuranosyl)-9H-purin-6-amine; NSC-83258; NSC-141848; NSC-143510; NSC83258; RefChem:439627; DTXCID701023135; 213-488-7; 683-408-7; NSC141848; NSC143510; (2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol; MFCD00005754; CCRIS 1782; AI3-52383; beta-D-erythro-Pentofuranoside, adenine-9 2-deoxy-; 2'-dA; NSC 83258; (2R,3S,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol; NSC 141848; NSC 143510; desoxyadenosin; 40627-14-3; 2'-Deoxyformycin A; 9-(2-Deoxy-|A-D-threo-pentofuranosyl)-9H-purin-6-amine; (2r,3s,5r)-5-(6-Amino-9h-Purin-9-Yl)-Tetrahydro-2-(Hydroxymethyl)furan-3-Ol; 3D1; 2'-deoxy-d-adenosine; Adenosine, 2'-deoxy,; EINECS 213-488-7; BRN 0091015; UNII-P582C98ULC; (3S,2R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 5-(6-AMINO-PURIN-9-YL)-2-HYDROXYMETHYL-TETRAHYDRO-FURAN-3-OL; 2-deoxy-adenosine; 2''''-Deoxyadenosine; 9-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)adenine; Epitope ID:167473; 2'-Deoxyadenosine(2'-dA); SCHEMBL19877; 4-26-00-03589 (Beilstein Handbook Reference); 2'-Deoxyadenosine (Standard); .beta.-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1,2-dideoxy-; CHEMBL449329; GTPL5109; orb1306771; orb1940558; orb3026065; SCHEMBL3691593; ACon0_001347; HY-W040329R; BDBM50453912; EBC-03910; MSK157318; SBB003141; AKOS015896793; CS-W021069; HY-W040329; (R)-1-C-(7-Amino-1H-pyrazolo(4,3-d)pyrimidin-3-yl)-1,4-anhydro-2-deoxy-D-erythro-pentitol; 2'-Deoxyadenosine monohydrate, >=99%; NCGC00161970-01; 2'-DEOXYADENOSINE [USP IMPURITY]; AS-14314; FD158139; ST057079; SY102597; 2 inverted exclamation marka-Deoxyadenosine; 2 inverted exclamation mark -Deoxyadenosine; HY-154058; CS-0674964; D0046; NS00014680; 9-(2-Deoxy-b-D-erythro-pentofuranosyl)adenine; adenine-9 2-deoxy-b-D-erythro-Pentofuranoside; Adenosine, 2'-deoxy- (6CI,7CI,8CI,9CI); C00559; EN300-108104; T20041; 9-(2-deoxy-b-D-ribofuranosyl)-9H-Purin-6-amine; Adenine-9 2-deoxy-beta-D-erythro-Pentofuranoside; F092055; Q422457; adenine-9 2-deoxy-beta-delta-erythro-Pentofuranoside; 9-(2'-Deoxy-.beta.-D-erythro-pentofuranosyl)adenine; 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)adenine; 9-(2-deoxy-beta-delta-ribofuranosyl)-9H-Purin-6-amine; Z1416201984; 1-(6-amino-9H-purin-9-yl)-1,2-dideoxy-b-D-Ribofuranose; 9-(2-deoxy-b-D-erythro-pentofuranosyl)-9H-Purin-6-amine; 1-(6-amino-9H-purin-9-yl)-1,2-dideoxy-beta-D-Ribofuranose; 9-(2-deoxy-beta-D-erythro-pentofuranosyl)-9H-Purin-6-amine; D2DF2A54-B4A8-4727-A05C-3D1123687898; [9-(2-Deoxy-|A-D-erythro-pentofuranosyl)-9H-purin-6-yl]amidogen; 1-(6-amino-9H-purin-9-yl)-1,2-dideoxy-beta-delta-Ribofuranose; 9-(2-deoxy-beta-delta-erythro-pentofuranosyl)-9H-Purin-6-amine; 2'-Deoxyadenosine monohydrate, powder, BioReagent, suitable for cell culture; 111876-57-4; 663188-78-1; D-erythro-Pentitol, 1-C-(7-amino-1H-pyrazolo(4,3-d)pyrimidin-3-yl)-1,4-anhydro-2-deoxy-, (R)-Sinónimos